Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adenylate Kinase 1
- Administration, Oral 1
- Administration, Rectal 1
- Adolescent 5
- Adult 8
- AIDS Serodiagnosis 1
- Anthrax 1
- Anti-HIV Agents 2
- Antibodies, Viral 2
- Antibody Formation 1
- Antitubercular Agents 3
- Article 2
- B-Lymphocytes 1
- Bacillus anthracis 1
- Bioterrorism 1
- Botswana 1
- CD4 Lymphocyte Count 2
- CD4-Positive T-Lymphocytes 1
- CD8-Positive T-Lymphocytes 1
- Chlamydia Infections 1
- Ciprofloxacin 1
- Clinical Studies as Topic 1
- Cohort Studies 5
- Coinfection 3
- Condoms 1
- Confidence Intervals 1
- Creatine Kinase, MM Form 1
- Cross-Over Studies 1
- Disease Outbreaks 1
- Dispatch 1
- DNA, Bacterial 1
- Double-Blind Method 1
- Drug-Related Side Effects and Adverse Reactions 2
- Emtricitabine / administration & dosage* 1
- Environmental Exposure 1
- Epidemics 2
- Epidemiology and Social 1
- False Negative Reactions 1
- Female 5
- Full Report 1
- Gels 1
- Genetic Variation 1
- Genotype 1
- Health Risk Behaviors 1
- Hemagglutination Inhibition Tests 3
- Hemagglutinin Glycoproteins, Influenza Virus 1
- Hepatitis A 1
- Hepatitis B 1
- Herpes Genitalis 1
- Herpes Simplex 1
- Herpesvirus 2, Human 1
- High-Throughput Nucleotide Sequencing 1
- HIV 2
- HIV-1 4
- HIV-2 1
- HIV Antibodies 1
- HIV Infections 10
- Homosexuality, Male 5
- Humans 14
- Immunity, Cellular 1
- Immunoenzyme Techniques 1
- Immunoglobulin A 1
- Immunoglobulin G 1
- Incidence 3
- Influenza, Human 3
- Influenza A Virus, H1N1 Subtype 1
- Influenza Vaccines 3
- Inhalation Exposure 1
- Injections, Intradermal 1
- Injections, Intramuscular 1
- Interferon-gamma 1
- Interleukin-2 1
- Kaplan-Meier Estimate 1
- Male 10
- Medication Adherence 1
- Microbial Sensitivity Tests 2
- Middle Aged 7
- Mycobacterium tuberculosis 2
- Odds Ratio 1
- Point-of-Care Systems 1
- Polymerase Chain Reaction 1
- Postal Service 1
- Pre-Exposure Prophylaxis 2
- Proportional Hazards Models 1
- Pyruvate Kinase 1
- Qualitative Research 1
- Reagent Kits, Diagnostic 1
- Recurrence 1
- Regression Analysis 1
- Research 1
- Risk Factors 2
- Sexual and Gender Minorities 3
- Sexual Partners 2
- Sputum 2
- Tenofovir 2
- Thailand 4
- Treatment Failure 2
- Tuberculosis, Multidrug-Resistant 3
- Viral Load 2
- Young Adult 5
Personal Author
Corporate Author
Place as Subject
- India 1
- Latvia 1
- New York City, NY 1
- South Africa 1
- Thailand 5
- United States 1
Resource Type General
Keywords
Select all docs (Max 200)
1 -
16 of 16 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adenylate Kinase (1)
- Administration, Oral (1)
- Administration, Rectal (1)
- Adolescent (5)
- Adult (8)
- AIDS Serodiagnosis (1)
- Anthrax (1)
- Anti-HIV Agents (2)
- Antibodies, Viral (2)
- Antibody Formation (1)
- Antitubercular Agents (3)
- Article (2)
- B-Lymphocytes (1)
- Bacillus anthracis (1)
- Bioterrorism (1)
- Botswana (1)
- CD4 Lymphocyte Count (2)
- CD4-Positive T-Lymphocytes (1)
- CD8-Positive T-Lymphocytes (1)
- Chlamydia Infections (1)
- Ciprofloxacin (1)
- Clinical Studies as Topic (1)
- Cohort Studies (5)
- Coinfection (3)
- Condoms (1)
- Confidence Intervals (1)
- Creatine Kinase, MM Form (1)
- Cross-Over Studies (1)
- Disease Outbreaks (1)
- Dispatch (1)
- DNA, Bacterial (1)
- Double-Blind Method (1)
- Drug-Related Side Effects and Adverse Reactions (2)
- Emtricitabine / administration & dosage* (1)
- Environmental Exposure (1)
- Epidemics (2)
- Epidemiology and Social (1)
- False Negative Reactions (1)
- Female (5)
- Full Report (1)
- Gels (1)
- Genetic Variation (1)
- Genotype (1)
- Health Risk Behaviors (1)
- Hemagglutination Inhibition Tests (3)
- Hemagglutinin Glycoproteins, Influenza Virus (1)
- Hepatitis A (1)
- Hepatitis B (1)
- Herpes Genitalis (1)
- Herpes Simplex (1)
- Herpesvirus 2, Human (1)
- High-Throughput Nucleotide Sequencing (1)
- HIV (2)
- HIV-1 (4)
- HIV-2 (1)
- HIV Antibodies (1)
- HIV Infections (10)
- Homosexuality, Male (5)
- Humans (14)
- Immunity, Cellular (1)
- Immunoenzyme Techniques (1)
- Immunoglobulin A (1)
- Immunoglobulin G (1)
- Incidence (3)
- Influenza, Human (3)
- Influenza A Virus, H1N1 Subtype (1)
- Influenza Vaccines (3)
- Inhalation Exposure (1)
- Injections, Intradermal (1)
- Injections, Intramuscular (1)
- Interferon-gamma (1)
- Interleukin-2 (1)
- Kaplan-Meier Estimate (1)
- Male (10)
- Medication Adherence (1)
- Microbial Sensitivity Tests (2)
- Middle Aged (7)
- Mycobacterium tuberculosis (2)
- Odds Ratio (1)
- Point-of-Care Systems (1)
- Polymerase Chain Reaction (1)
- Postal Service (1)
- Pre-Exposure Prophylaxis (2)
- Proportional Hazards Models (1)
- Pyruvate Kinase (1)
- Qualitative Research (1)
- Reagent Kits, Diagnostic (1)
- Recurrence (1)
- Regression Analysis (1)
- Research (1)
- Risk Factors (2)
- Sexual and Gender Minorities (3)
- Sexual Partners (2)
- Sputum (2)
- Tenofovir (2)
- Thailand (4)
- Treatment Failure (2)
- Tuberculosis, Multidrug-Resistant (3)
- Viral Load (2)
- Young Adult (5)
- :Mitchell, Kate M. ;Dimitrov, DobromirMar 27 2018 | AIDS. 2018; 32(6):809-818.:Objectives:To review the main factors influencing the costs of nondaily oral preexposure prophylaxis (PrEP) with tenofovir (±emtricitabine). To estim...
- :Mitnick, Carole D. ;White, Richard A.Sep 01 2016 | Eur Respir J. 2016; 48(4):1160-1170.:Debate persists about monitoring method (culture or smear) and interval (monthly or less frequently) during treatment for multidrug-resistant tubercul...
- :Leelawiwat, Wanna ;Pattanasin, SarikaJul 31 2018 | PLoS One. 13(7).:BackgroundDifferences between HIV genotypes may affect HIV disease progression. We examined infecting HIV genotypes and their association with disease...
- :Figueroa, Dominique B. ;Tillotson, JosephApr 11 2018 | PLoS One. 13(4).:Tenofovir (TFV), a nucleotide reverse transcriptase inhibitor, requires two phosphorylation steps to form a competitive inhibitor of HIV reverse trans...
- :Carballo-Diéguez, Alex ;Balán, Ivan C.Jul 27 2017 | PLoS One. 12(7).:Trials to assess microbicide safety require strict adherence to prescribed regimens. If adherence is suboptimal, safety cannot be adequately assessed....
- :Skenders, Girts ;Fry, Alicia M.Sep 2005 | Emerg Infect Dis. 11(9):1461-1463.:To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national l...
- :Garg, Shikha ;Thongcharoen, PrasertOct 20 2015 | Clin Infect Dis. 62(3):383-391.:BackgroundIndividuals infected with human immunodeficiency virus (HIV) are at increased risk for severe influenza, yet immune responses to standard-do...
- :Curlin, Marcel E. ;Gvetadze, RomanJun 15 2017 | Clin Infect Dis. 64(12):1663-1669:BackgroundThe OraQuick Advance Rapid HIV-1/2 Test is a point-of-care test capable of detecting human immunodeficiency virus (HIV)-specific antibodies ...
- :Garg, Shikha ;Olsen, Sonja J.Oct 10 2014 | Open Forum Infect Dis. 2014; 1(3).:Among 368 Thai men who have sex with men with paired serum samples collected before and during the 2009 H1N1 influenza pandemic, we determined influen...
- :Thienkrua, Warunee ;Todd, Catherine S.Jul 22 2016 | BMC Infect Dis. 16.:BackgroundHigh HIV incidence has been detected among men who have sex with men (MSM) in Thailand, but the relationship and timing of HIV, herpes simpl...
- :Chemnasiri, Tareerat ;Beane, Chelsey R.February 02 2018 | J Homosex. 66(4):533-548:The Bangkok Men Who Have Sex With Men (MSM) Cohort Study has shown high HIV incidence (8-12/100 person-years) among 18-21-year-old MSM. These data led...
- :Ahuja, Shama D. ;Ashkin, DavidAug 28 2012 | PLoS Med. 2012; 9(8).:BackgroundTreatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an indivi...
- :Holtz, Timothy H. ;Ackelsberg, JoelJun 2003 | Emerg Infect Dis. 9(6):689-696.:On October 31, 2001, in New York City, a 61-year-old female hospital employee who had acquired inhalational anthrax died after a 6-day illness. To det...
- :Amoah, Samuel ;Mishina, Margarita7 31 2019 | J Infect Dis. 220(5):743-751:Background.Human immunodeficiency virus (HIV)–infected persons are at a higher risk of severe influenza. Although we have shown that a standard-dose...
- :Mitruka, Kiren ;Bamrotiya, ManishNov 30 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.